A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma

被引:2
|
作者
Zhang, Hai-Feng [1 ,2 ]
Delaidelli, Alberto [1 ,2 ]
Javed, Sumreen [3 ]
Turgu, Busra [1 ,2 ]
Morrison, Taylor [2 ]
Hughes, Christopher S. [1 ,2 ]
Yang, Xiaqiu [2 ]
Pachva, Manideep [1 ,2 ]
Lizardo, Michael M. [1 ,2 ]
Singh, Gurdeep [2 ]
Hoffmann, Jennifer [4 ,5 ]
Huang, Yue Zhou [2 ]
Patel, Khushbu [4 ,5 ,6 ]
Shraim, Rawan [4 ,5 ,7 ]
Kung, Sonia H. Y. [8 ]
Morin, Gregg B. [9 ,10 ]
Aparicio, Samuel [1 ,2 ]
Martinez, Daniel [4 ,5 ,6 ]
Maris, John M. [4 ,5 ,6 ]
Bosse, Kristopher R. [4 ,5 ,6 ]
Williams, Karla C. [3 ]
Sorensen, Poul H. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, 2211 Wesbrook Mall, Vancouver, BC V6T 1Z4, Canada
[2] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[7] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA
[8] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[9] Canadas Michael Smith Genome Sci Ctr, Vancouver V5Z 4S6, BC, Canada
[10] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T1Z4, Canada
基金
加拿大健康研究院;
关键词
MIGRATION INHIBITORY FACTOR; DEAD BOX GENE; PLEIOTROPIC ROLE; GREB1; MEDULLOBLASTOMA; COAMPLIFICATION; EXPRESSION; MORPHOLOGY; REGULATOR; PROTEINS;
D O I
10.1126/sciadv.adg6693
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MYCN amplification (MNA) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the MYCN amplicon also contribute to MNA(+) NB remains poorly understood. Here, we identify that GREB1, a transcription factor encoding gene neighboring the MYCN locus, is frequently coexpressed with MYCN and promotes cell survival in MNA(+) NB. GREB1 controls gene expression independently of MYCN, among which we uncover myosin 1B (MYO1B) as being highly expressed in MNA(+) NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regulator of invasion and metastasis. Global secretome and proteome profiling further delineates MYO1B in regulating secretome reprogramming in MNA(+) NB cells, and the cytokine MIF as an important pro-invasive and pro-metastatic mediator of MYO1B activity. Together, we have identified a putative GREB1-MYO1B-MIF axis as an unconventional mechanism promoting aggressive behavior in MNA(+) NB and independently of MYCN.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes
    Sarkar, AK
    Nuchtern, JG
    CANCER RESEARCH, 2000, 60 (07) : 1908 - 1913
  • [22] Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
    Rounbehler, Robert J.
    Li, Weimin
    Hall, Mark A.
    Yang, Chunying
    Fallahi, Mohammad
    Cleveland, John L.
    CANCER RESEARCH, 2009, 69 (02) : 547 - 553
  • [23] EXOSOMES FROM MYCN-AMPLIFIED NEUROBLASTOMA CONTAIN ONCOGENIC MICRORNAS
    Flaegstad, T.
    Haug, B. H.
    Hald, O.
    Utnes, P.
    Lokke, C.
    Einvik, C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S329 - S329
  • [24] Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
    Øyvind H. Hald
    Lotte Olsen
    Gabriel Gallo-Oller
    Lotta Helena Maria Elfman
    Cecilie Løkke
    Per Kogner
    Baldur Sveinbjörnsson
    Trond Flægstad
    John Inge Johnsen
    Christer Einvik
    Oncogene, 2019, 38 : 2800 - 2813
  • [25] Striking Dichotomy in Outcome of MYCN-Amplified Neuroblastoma in the Contemporary Era
    Kushner, Brian H.
    Modak, Shakeel
    Kramer, Kim
    LaQuaglia, Michael P.
    Yataghene, Karima
    Basu, Ellen M.
    Roberts, Stephen S.
    Cheung, Nai-Kong V.
    CANCER, 2014, 120 (13) : 2050 - 2059
  • [26] MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
    Aygun, Nevim
    Altungoz, Oguz
    MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 345 - 361
  • [27] Exploit the zebrafish to study lymphocyte infiltration in MYCN-amplified neuroblastoma
    Qin, Xiaodan
    Lam, Andrew
    Feng, Hui
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [28] Inhibitors of Ribosome Biogenesis Repress the Growth of MYCN-Amplified Neuroblastoma
    Olsen, L.
    Hald, O.
    Gallo-Oller, G.
    Elfmann, L.
    Lokke, C.
    Kogner, P.
    Sveinbjornsson, B.
    Flaegstad, T.
    Johnsen, J. I.
    Eivik, C.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S337 - S337
  • [29] MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas
    Mohan, Divya
    Nambirajan, Aruna
    Malik, Rafat
    Sharma, Agrima
    Suri, Vaishali
    Kaur, Kavneet
    Doddamani, Ramesh
    Garg, Ajay
    Gupta, Subhash
    Mallick, Supriya
    Sharma, Mehar Chand
    HUMAN CELL, 2024, 37 (03) : 704 - 713
  • [30] The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
    Faisal, Amir
    Vaughan, Lynsey
    Bavetsias, Vassilios
    Sun, Chongbo
    Atrash, Butrus
    Avery, Sian
    Jamin, Yann
    Robinson, Simon P.
    Workman, Paul
    Blagg, Julian
    Raynaud, Florence I.
    Eccles, Suzanne A.
    Chesler, Louis
    Linardopoulos, Spiros
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2115 - 2123